For the first time, a CRISPR drug treats a child’s unique mutation
Title: Landmark CRISPR Therapy Targets Rare Genetic Defect in Pediatric Patient
Original: Researchers are optimistic that this breakthrough will pave the way for broader therapeutic applications for other young patients.
Source: The Economist Generated at: 2025-05-15 17:00:00 UTC






